BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 6697294)

  • 1. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
    Murphy WM; Soloway MS; Jukkola AF; Crabtree WN; Ford KS
    Cancer; 1984 Apr; 53(7):1555-65. PubMed ID: 6697294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
    Ylagan LR; Humphrey PA
    Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine cytology in bladder tumors.
    Zein TA; Milad MF
    Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of dysplasia associated with bladder cancer--histopathological findings of bladder giant sections and related urinary cytology].
    Sekine H
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):545-54. PubMed ID: 2747096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of urinary cytology in the evaluation of bladder neoplasms.
    Murphy WM
    Hum Pathol; 1990 Sep; 21(9):886-96. PubMed ID: 2203672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine.
    Renshaw AA; Nappi D; Weinberg DS
    Acta Cytol; 1996; 40(4):676-82. PubMed ID: 8693885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL; Wojcik EM
    Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis.
    Raab SS; Lenel JC; Cohen MB
    Cancer; 1994 Sep; 74(5):1621-6. PubMed ID: 8062194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
    Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
    Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
    Whisnant RE; Bastacky SI; Ohori NP
    Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.
    Gourlay W; Chan V; Gilks CB
    Mod Pathol; 1995 May; 8(4):394-7. PubMed ID: 7567937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
    Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
    Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of "cannibalism" in urinary cytology of bladder cancer.
    Kojima S; Sekine H; Fukui I; Ohshima H
    Acta Cytol; 1998; 42(6):1365-9. PubMed ID: 9850644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cytology for carcinoma in situ of the urinary bladder.
    Rosa B; Cazin M; Dalian G
    Acta Cytol; 1985; 29(2):117-24. PubMed ID: 3856981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings.
    Chu YC; Han JY; Han HS; Kim JM; Suh JK
    Acta Cytol; 2002; 46(2):341-8. PubMed ID: 11917583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.